AzTrials
AzTrials

HemiparesisPhase 1NCT00878085

Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living

A Phase 1 study testing Robot Therapy Device and Occupational Therapy in people with Hemiparesis and Ischemic Stroke, run by Medical College of Wisconsin at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will study motor recovery after robot-assisted therapy after stroke. A small clinical trial will be conducted to quantify the central nervous system changes associated with robotic or standard training, and identify trends across high and low responders in terms of patterns of change in cortical… Read more about this study

Who is it for?
Ages 30 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Hemiparesis, Ischemic Stroke, Chronic
What is being tested?
Robot Therapy Device and Occupational Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
2 sitesUnited States
Study dates
Nov 2008to Jun 2013
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Stroke:
  • 30 to 85 years
  • Right-handed (evaluated with handedness survey)
  • suffered a unilateral ischemic stroke in the motor control area, which resulted in hemiparesis of the arm (confirmed by medical data),
  • at least 6-months post-stroke
  • residual movement at least (a) 15 degree shoulder flexion or adduction, (b) 15 degree active elbow flexion and extension
Show all 16Show fewer
  • not claustrophobic
  • not depressed (as measured depression survey)
  • able to use the scanner, i.e., passes the fMRI screening survey
  • able to understand the instructions and complete the tracking tasks Control
  • older than 20 years
  • Right-handed (evaluated with survey)
  • not claustrophobic
  • able to use the scanner, i.e., passes the fMRI screening survey
  • able to understand the instructions and complete the tracking tasks
  • no history of neurological disorders --not depressed (as measured depression survey)

Who cannot join

  • Stroke:
  • brain stem, stroke
  • pre-existing neurological or psychiatric disorders
  • Spasticity >3 at elbow or fingers on Ashworth
  • demonstrated visuospatial, language or attention deficits of a severity that prevents understanding the task
  • shoulder pain or joint pain during movements
Show all 16Show fewer
  • synkinetic movements or mirror movements
  • decline to participate
  • will not comply with full protocol
  • pregnant
  • allergic to goretex and conductivity gel
  • Control
  • decline to participate
  • will not comply with full protocol
  • pregnant
  • allergic to goretex and conductivity gel

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226

  • Clement J Zablocki VA

    Milwaukee, Wisconsin, 53295

Other trials in United States

About this study

Official title: fMRI and Robot-Assisted Practice of Activities of Daily Living

The investigators will study motor recovery after robot-assisted therapy after stroke. A small clinical trial will be conducted to quantify the central nervous system changes associated with robotic or standard training, and identify trends across high and low responders in terms of patterns of change in cortical activity and type of white matter connectivity.The investigators hypothesize that robot training will lead to larger improvements as compared to standard occupational therapy. The investigators hypothesize that high responders to the robot training will have reduced compensatory activation in the bilateral area and will connectivity in the motor tracts.

Read the detailed description

Robot-assisted therapy is on the cutting edge of stroke rehabilitation and is a therapy method that promises to improve the lives of persons with disabilities due to stroke. Preliminary studies using these tools provide mixed evidence for their effectiveness and reveal limitations. For example, inconsistent carryover of motor gains to real life activities of daily living (ADLs) is seen. Therefore, it is still not clear what treatment strategies maximize functional outcomes on ADLs. There is a need to study the stroke recovery process and to understand how to optimize robot-assisted therapies in order to enhance patient rehabilitation and improve functional outcomes. Imaging techniques such as functional Magnetic Resonance Imaging (fMRI) and Diffusion Tensor Imaging (DTI) can assist us in understanding the stroke recovery process, in determining who may benefit from robot-assisted training, and in defining how training induced functional cortical changes occur after robot training. We propose to conduct an interventional study plus control to assess the effectiveness of four weeks of robot-assisted practice of tasks with skilled functional tasks that involve reaching and grasping activities similar to real activities. We will examine the process of recovery for low-to-moderate functioning stroke survivors with chronic disability. We will assess the ability of active-assisted reaching and grasping training to effect immediate gains and long-term functional improvements. Further, using fMRI and DTI, we plan to associate changes seen in motor impairment levels and functional task performance levels with white matter injuries and connectivity and changes in oxygen utilization in the motor cortex as well as other areas of the brain. Our short-term aims are to, i) assess short-term functional gains after practice of skilled reaching and grasping tasks; ii) assess maintenance of these improvements; iii) quantify the neuronal changes associated with short-term gains, and iv) identify trends across high and low responders in terms of patterns of change in cortical activity and type of white matter connectivity. In the long-term, we hope to improve understanding of the process of ADL functional recovery after stroke and optimize robot-training strategies leading to cerebral plasticity. We also hope to determine how lesion characteristics affect changes seen in function, white matter connectivity, and cortical activity. By, accomplishing these aims, we hope to improve upper extremity function after stroke and reduce disability.

Being tested
Robot Therapy Device, Occupational Therapy
Keywords
Robot Therapy, Upper Limb, Stroke, Rehabilitation, fMRI, DTI
Medical subject headings
Paresis, Ischemic Stroke, Bronchiolitis Obliterans Syndrome, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Robot Therapy DeviceDevice

    3x a week for 4 weeks

  • Occupational TherapyBehavioural

    3x a week for 4 weeks

Study groups in NCT00878085
Study groupRoleWhat they receive
1ExperimentalRobot Therapy with activities of daily living (ADLs)
Receives: Device: Robot Therapy Device
2Active comparatorStandard Occupational Therapy
Receives: Behavioral: Occupational Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Measures: Fugl-Meyer (Motor control), Functional Hand Evaluation (ADL), Jebsen Taylor

    Measured: Pre (2x) , Post, Follow-Up

  2. Biomechanical:Movement Time, Grasp Aperture, Movement Smoothness

    Measured: Pre (2x), Post, Follow-up

  3. Imaging Measures: BOLD response (activation), Laterality Index, Fractional Anisotropy, Fiber Density Index

    Measured: Pre (1x), Post, Follow-up

Secondary outcomes (2)
  1. Clinical Measures: Joint ROM, MMT, Spasticity

    Measured: Pre(2x), Post, Follow-up

  2. Clinical Measures: Pain, Exertion

    Measured: During Therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2009 (estimated)
  2. Study startNov 2008
  3. Primary completionJun 2013
  4. Study completionJun 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
61 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00878085
Sponsor's protocol ID
HR
Other IDs
NIH 1K25NS058577 - 01A1
Status last verified
Feb 2014
First submitted
23 Mar 2009
Last updated
4 Feb 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Robot Therapy Device and Occupational Therapy in people with Hemiparesis and Ischemic Stroke, run by Medical College of Wisconsin at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Measures: Fugl-Meyer (Motor control), Functional Hand Evaluation (ADL), Jebsen Taylor (time frame: Pre (2x) , Post, Follow-Up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in